A Phase I, Open Label, Randomized, 4-way Crossover Trial to Evaluate the Pharmacokinetics of TMC278 25mg and 50mg in the Presence of Omeprazole 20mg q.d., in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 08 Jul 2010
At a glance
- Drugs Omeprazole; Rilpivirine
- Indications Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Helicobacter infections; HIV infections; Peptic ulcer; Zollinger-Ellison syndrome
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 08 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 May 2010 Actual patient number (18) added as reported by ClinicalTrials.gov.
- 01 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.